BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4969882)

  • 1. Poliovirus Type 1. Preparation of a suitable antigen for gel diffusion study.
    Ray S
    J Indian Med Assoc; 1968 May; 50(9):403-7. PubMed ID: 4969882
    [No Abstract]   [Full Text] [Related]  

  • 2. The concentration of poliovirus antigens for D-antigen determination.
    van Ramshorst JD
    Bull World Health Organ; 1967; 36(2):209-18. PubMed ID: 4965451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods.
    van der Marel P; Hazendonk AG; van Wezel AL
    Dev Biol Stand; 1981; 47():101-8. PubMed ID: 6262140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monitoring of antigen levels during inactivated poliovirus vaccine production: evaluation of filtration techniques.
    Moynihan M; Petersen I
    Dev Biol Stand; 1981; 50():243-8. PubMed ID: 6804290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.
    Souvras M; Montagnon B; Fanget B; van Wezel AL; Hazendonk AG
    Dev Biol Stand; 1980; 46():197-202. PubMed ID: 6244997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
    Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
    Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence and quantification of cell substrate DNA in inactivated poliovirus vaccine.
    Crainic R; Horodniceanu F; Barme M
    Dev Biol Stand; 1980; 46():275-9. PubMed ID: 6245003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of poliovirus antigen measurements in vitro and in small animals.
    von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
    Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen content of inactivated poliovirus vaccine for use in a one- or two-dose regimen.
    Salk J; Stoeckel P; van Wezel AL; Lapinleimu K; van Steenis G
    Ann Clin Res; 1982 Dec; 14(5-6):204-12. PubMed ID: 7171229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
    Rezapkin G; Dragunsky E; Chumakov K
    Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G; Martin J; Chumakov K
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration and purification of poliovirus by immune adsorption on immobilized antibodies.
    van der Marel P; van Wezel AL; Hazendonk AG; Kooistra A
    Dev Biol Stand; 1980; 46():267-73. PubMed ID: 6245002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 1.
    Glikmann G; Moynihan M; Petersen I; Vestergaard BF
    Dev Biol Stand; 1983; 55():199-208. PubMed ID: 6203794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines.
    Wood DJ; Heath AB
    Biologicals; 1995 Dec; 23(4):301-11. PubMed ID: 8825859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency testing of killed polio vaccine in rats.
    van Steenis G; van Wezel AL; Sekhuis VM
    Dev Biol Stand; 1981; 47():119-28. PubMed ID: 6262142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
    Moynihan M; Ladefoged P; Mathiesen L
    Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines based on recombinant antigen strategies.
    Minor P
    Dev Biol (Basel); 2001; 105():189-94. PubMed ID: 11763327
    [No Abstract]   [Full Text] [Related]  

  • 20. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.